Plasma &bgr;-amyloid and MRI markers of cerebral small vessel disease: Three-City Dijon Study

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neurology

• Publication date

  2014-11-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.0000000000001038PMID 25355827
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cerebral amyloid angiopathy burden associated with leukoaraiosis: A positron emission tomography/magnetic resonance imaging study

  2013cited by this paper
• Brain and Circulating Levels of A&bgr;1–40 Differentially Contribute to Vasomotor Dysfunction in the Mouse Brain

  2013cited by this paper
• Innate immunity receptor CD36 promotes cerebral amyloid angiopathy

  2013cited by this paper
• Risk Factors for -Amyloid Deposition in Healthy Aging Vascular and Genetic Effects

  2013cited by this paper
• Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging.

  2013cited by this paper
• Neurovascular decoupling is associated with severity of cerebral amyloid angiopathy

  2013cited by this paper
• Midlife Blood Pressure, Plasma &bgr;-Amyloid, and the Risk for Alzheimer Disease: The Honolulu Asia Aging Study

  2012influential reference
• Neurovascular Defects and Faulty Amyloid-β Vascular Clearance in Alzheimer's Disease

  2012cited by this paper
• White matter hyperintensities predict amyloid increase in Alzheimer's disease.

  2012influential reference
• Cerebrovascular disease, β-amyloid, and cognition in aging.

  2012cited by this paper
• White Matter Lesions Are Not Related to β-Amyloid Deposition in an Autopsy-Based Study

  2011cited by this paper
• Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

  2011influential reference
• Genome‐wide association studies of cerebral white matter lesion burden

  2011cited by this paper
• Cerebral amyloid angiopathy in the elderly

  2011cited by this paper
• Could changes in arterioles impede the perivascular drainage of interstitial fluid from the cerebral white matter in leukoaraiosis?

  2010cited by this paper
• Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

  2010influential reference
• The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis

  2010cited by this paper
• High Degree of Dilated Virchow-Robin Spaces on MRI is Associated with Increased Risk of Dementia

  2010cited by this paper
• Association of plasma amyloid β with risk of dementia

  2009cited by this paper
• Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances.

  2009cited by this paper
• Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderly

  2009cited by this paper
• Biomarkers for cognitive impairment and dementia in elderly people.

  2008influential reference
• Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms

  2008cited by this paper
• Silent brain infarcts: a systematic review.

  2007cited by this paper
• Associations between white matter lesions, cerebrovascular risk factors, and low CSF Aβ42

  2006cited by this paper
• Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans

  2006influential reference
• Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

  2006cited by this paper
• Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD

  2006cited by this paper
• Plasma β-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy

  2006cited by this paper
• Associations between white matter lesions, cerebrovascular risk factors, and low CSF Abeta42.

  2006cited by this paper
• Stereologic Analysis of Microvascular Morphology in the Elderly: Alzheimer Disease Pathology and Cognitive Status

  2006cited by this paper
• Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy

  2006influential reference
• The age-dependent relation of blood pressure to cognitive function and dementia.

  2005cited by this paper
• Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

  2005cited by this paper
• White matter lesion progression, brain atrophy, and cognitive decline: The Austrian stroke prevention study

  2005cited by this paper
• Amyloid Angiopathy–Related Vascular Cognitive Impairment

  2004cited by this paper
• Neurovascular regulation in the normal brain and in Alzheimer's disease

  2004cited by this paper
• Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesions

  2004influential reference
• The impact of cerebrovascular lesions in Alzheimer disease

  2003cited by this paper
• Brain to Plasma Amyloid-β Efflux: a Measure of Brain Amyloid Burden in a Mouse Model of Alzheimer's Disease

  2002cited by this paper
• Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis

  2002influential reference
• Serum creatinine levels correlate with plasma amyloid β protein

  2002cited by this paper
• Serum Creatinine Levels Correlate With Plasma Amyloid &bgr; Protein

  2002cited by this paper
• Cerebral Amyloid Angiopathy in the Elderly

  1981cited by this paper

• Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer’s disease and candidate genetic biomarkers for treatment stratification

  2025cites this paper
• Comparison of the clinical value of MRI and plasma markers for cognitive impairment in patients aged ≥75 years: a retrospective study

  2023cites this paper
• The cross-sectional association between amyloid burden and white matter hyperintensities in older adults without cognitive impairment: a systematic review and meta-analysis.

  2023cites this paper
• Elevated Plasma Oligomeric Amyloid β-42 Is Associated with Cognitive Impairments in Cerebral Small Vessel Disease

  2023cites this paper
• Altered serum amyloid beta and cerebral perfusion and their associations with cognitive function in patients with subcortical ischemic vascular disease

  2022cites this paper
• Assessing the effectiveness of statin therapy for alleviating cerebral small vessel disease progression in people ≥75 years of age

  2020cites this paper
• Stroke Biomarkers

  2020cites this paper
• Characterization of White Matter Hyperintensities in Large-Scale MRI-Studies

  2019cites this paper
• Association of variants in HTRA1 and NOTCH3 with MRI-defined extremes of cerebral small vessel disease in older subjects

  2019influential citation
• Neuroimaging of Cerebral Small Vessel Disease and Age-Related Cognitive Changes

  2019cites this paper
• Late-onset unexplained epilepsy: What are we missing?

  2019cites this paper
• Cerebrovascular disease: Neuroimaging of cerebral small vessel disease.

  2019cites this paper
• Plasma Amyloid Is Associated with White Matter and Subcortical Alterations and Is Modulated by Age and Seasonal Rhythms in Mouse Lemur Primates

  2018influential citation
• Unraveling the heterogeneity of cerebral small vessel disease. From local to remote effects

  2018cites this paper
• Plasma A&bgr; (Amyloid-&bgr;) Levels and Severity and Progression of Small Vessel Disease

  2018cites this paper
• A population neuroscience approach to the study of cerebral small vessel disease in midlife and late life: an invited review.

  2018cites this paper
• Topography and Determinants of Magnetic Resonance Imaging (MRI)‐Visible Perivascular Spaces in a Large Memory Clinic Cohort

  2017cites this paper
• Blood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicability

  2016cites this paper
• Long-Term Clinical Impact of Vascular Brain Lesions on Magnetic Resonance Imaging in Older Adults in the Population

  2016cites this paper
• Longitudinal change of small-vessel disease-related brain abnormalities

  2016cites this paper
• The Relationship Between Plasma Aβ Levels, Cognitive Function and Brain Volumetrics: Sydney Memory and Ageing Study.

  2016cites this paper
• Effects of DHA Supplementation on Hippocampal Volume and Cognitive Function in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized, Double-Blind, Placebo-Controlled Trial

  2016cites this paper
• White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β

  2016cites this paper
• Cerebral Amyloid and Hypertension are Independently Associated with White Matter Lesions in Elderly

  2015influential citation